Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 1/2 6Phase 3 3Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × penpulimab × Clear all
NCT06297642 2024-08-06

TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Terminated
3 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT06010901 2024-01-23

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
75 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡